Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03829683 · ClinicalTrials.gov registry record · Phase 2
Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis
A Phase 2 study, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT03829683 is a Phase 2 study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 20 participants.
The verdict
NCT03829683, a Phase 2 study, has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
The purpose of this research study is to test the safety, tolerability, and effectiveness of Vitamin C (ascorbic acid) intravenous infusion when used to treat alcoholic hepatitis (inflammation of the liver from heavy alcohol use) and sepsis (life-threatening complication of an infection).
Interventions
- DRUG Vitamin C
- DRUG Dextrose 5% in water
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2022-06-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03829683
The ClinicalTrials.gov registry entry for NCT03829683 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Vitamin C is the first listed.
NCT03829683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03829683 about?
NCT03829683 is a clinical study titled "Vitamin C Infusion for TReatment in Sepsis and Alcoholic Hepatitis". The purpose of this research study is to test the safety, tolerability, and effectiveness of Vitamin C (ascorbic acid) intravenous infusion when used to treat alcoholic hepatitis (inflammation of the liver from heavy alcohol use) and sepsis (life-threatening complication of an infection).
What is the current status of trial NCT03829683?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2019-04-16. Estimated completion is 2022-06-23.
What interventions are being tested in trial NCT03829683?
The interventions under investigation include: Vitamin C (DRUG), Dextrose 5% in water (DRUG).
Who is sponsoring clinical trial NCT03829683?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.